The NCCN has added zongertinib to its guidelines for the care of patients with HER2 (ERBB2)-mutated non–small cell lung cancer.

Oncology nurses play a key role in monitoring, managing, and personalizing CDK4/6 inhibitor treatment to minimize toxicities ...

A breast cancer survivorship expert shares her top advice for counseling patients on endocrine therapy at the 5-year mark.

Barriers to CAR T-cell therapy exist for patients with multiple myeloma, even in urban areas, said Mary Steinbach, DNP, APRN, ...

Nurses should be familiar with PET scan protocol and what to ask patients with lung and bone cancers before administering biology-guided radiation therapy.

A care model led by advanced practice nurses was feasible in providing supportive care and linking providers through ...

Panelists discuss how evolving clinical advances and biomarker-driven therapies have transformed treatment practices and ...

Panelists discuss how they manage adverse events associated with ALK inhibitors, comparing safety profiles and addressing ...

Panelists discuss how they approach long-term monitoring and follow-up care for ALK+ patients to maintain optimal outcomes on ...

Panelists discuss how practice improvements and patient resources can be implemented to empower both healthcare providers and ...

Panelists discuss how patient education strategies support long-term treatment success, adherence, and shared decision-making ...

Panelists discuss how patient-specific factors, including brain metastases and drug tolerability, influence front-line ALK ...